查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598834

血管栓塞市場：按栓塞技術、應用和最終用戶分類 - 全球預測 2025-2030

Vascular Embolization Market by Embolization Technique (Coiling Devices, Non-Coiling Devices), Application (Neurology, Oncology, Peripheral Vascular Disease), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血管栓塞市場價值為20.9億美元，預計2024年將達到23.2億美元，複合年成長率為11.38%，到2030年將達到44.5億美元。

血管栓塞是一種微創醫療手術，用於故意阻塞血管以阻止血液流向特定區域。該手術對於治療多種疾病至關重要，包括控制出血、治療動脈瘤以及透過剝奪腫瘤的血液供應來治療腫瘤。其應用涵蓋多種醫學專業，包括腫瘤學、神經學和創傷護理。最終用途範圍主要包括醫院、門診手術中心以及能夠進行先進診斷影像和導管插入術的專科診所。影響血管栓塞市場成長的主要因素包括癌症和血管疾病盛行率的上升、微創技術的進步以及對專用栓塞設備的需求不斷增加。世界人口老化也進一步增加了栓塞治療的需求。新興市場、不斷上漲的醫療成本以及影像和微導管技術的技術進步帶來了巨大的成長機會。此外，個人化醫療的日益普及也為市場進入者提供了開拓的潛力。然而，它面臨著諸如栓塞技術和設備的高成本、熟練專家的有限性以及與非標靶栓塞等手術相關的潛在併發症挑戰。嚴格的監管核准流程也阻礙了新產品的快速推出。創新機會在於開發生物分解性的栓塞劑、改進更精確的輸送系統以及改進即時成像技術以提高手術的準確性和安全性。公司可以專注於投資研發、建立策略夥伴關係以利用先進技術，並擴展到新興市場以實現成長。市場競爭激烈，技術進步迅速，持續創新和策略規劃對於永續成長至關重要。

主要市場統計
基準年[2023] 20.9億美元
預測年份 [2024] 23.2億美元
預測年份 [2030] 44.5億美元
複合年成長率（%） 11.38%

市場動態：揭示快速發展的血管栓塞市場的關鍵市場洞察

供需的動態交互作用正在改變血管栓塞市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 血管疾病盛行率增加
    • 人們越來越偏好微創治療
    • 栓塞產品和程序的開發
  • 市場限制因素
    • 栓塞相關的高成本
  • 市場機會
    • 血管栓塞生物材料和技術的進展
  • 市場挑戰
    • 與栓塞相關的併發症

波特五力：駕馭血管栓塞市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解血管栓塞市場的外部影響

外部宏觀環境因素在塑造血管栓塞市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解血管栓塞市場的競爭狀況

血管栓塞市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣式血管栓塞市場供應商的績效評估

FPNV 定位矩陣是評估血管栓塞市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了血管栓塞市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對血管栓塞市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 血管疾病盛行率增加
      • 人們對微創手術的興趣日益濃厚
      • 栓塞產品和程序的開發
    • 抑制因素
      • 栓塞相關的高成本
    • 機會
      • 血管栓塞生醫材料和技術的進展
    • 任務
      • 與栓塞相關的併發症
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依栓塞技術分類的血管栓塞市場

  • 線圈裝置
  • 非捲繞裝置

第7章血管栓塞市場：依應用分類

  • 神經病學
  • 腫瘤學
  • 周圍血管疾病
  • 泌尿系統

第8章血管栓塞市場：依最終用戶分類

  • 門診手術中心
  • 診斷中心
  • 醫院
  • 專科診所

第9章北美及南美血管栓塞市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太血管栓塞市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲血管栓塞市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • Kaneka Corporation
  • Lepu Medical Technology Co.,Ltd.
  • Medtronic PLC
  • Merit Medical Systems Inc.
  • Penumbra Inc
  • Shape Memory Medical Inc.
  • Stryker Corporation
  • Terumo Corporation
  • WL Gore & Associates Inc.
  • WEGO Healthcare Co., Ltd.
Product Code: MRR-742BD5184D4D

The Vascular Embolization Market was valued at USD 2.09 billion in 2023, expected to reach USD 2.32 billion in 2024, and is projected to grow at a CAGR of 11.38%, to USD 4.45 billion by 2030.

Vascular embolization is a minimally invasive medical procedure used to intentionally block a blood vessel to prevent blood flow to a specific area. This procedure is vital in treating a variety of medical conditions, including controlling bleeding, managing aneurysms, and treating tumors by starving them of their blood supply. Its application spans across various medical specialties such as oncology, neurology, and trauma care. The end-use scope primarily includes hospitals, ambulatory surgical centers, and specialized clinics where advanced imaging and catheterization equipment are available. Key factors influencing the growth of the vascular embolization market include the rising prevalence of cancer and vascular diseases, advancements in minimally invasive techniques, and increasing demand for specialized embolization devices. An aging global population further fuels the demand for these procedures. Emerging markets, increasing healthcare expenditure, and technological advancements in imaging and micro-catheter technology present substantial growth opportunities. Additionally, the increasing adoption of personalized medicine offers untapped potential for market players. However, the market faces challenges such as the high cost of embolization procedures and devices, limited availability of skilled professionals, and potential complications associated with the procedure, such as non-target embolization. Stringent regulatory approval processes can also hurdle the rapid introduction of new products. Innovation opportunities lie in the development of biodegradable embolic agents, enhancing delivery systems for better precision, and improving real-time imaging technologies to increase the accuracy and safety of procedures. Businesses can focus on investing in R&D, forming strategic partnerships to leverage advanced technologies, and expanding into emerging markets to capture growth. The market's nature is characterized by high competition and rapid technological advancements, making continuous innovation and strategic planning essential for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.09 billion
Estimated Year [2024] USD 2.32 billion
Forecast Year [2030] USD 4.45 billion
CAGR (%) 11.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Embolization Market

The Vascular Embolization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of vascular diseases
    • Increasing preference for minimally invasive procedures
    • Development in embolization products and procedures
  • Market Restraints
    • High costs associated with embolization procedures
  • Market Opportunities
    • Advances in biomaterials and technologies for vascular embolization
  • Market Challenges
    • Complications associated with embolization procedures

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Embolization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Embolization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Embolization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Embolization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Embolization Market

A detailed market share analysis in the Vascular Embolization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Embolization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Embolization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Embolization Market

A strategic analysis of the Vascular Embolization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Embolization Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical Inc., Kaneka Corporation, Lepu Medical Technology Co.,Ltd., Medtronic PLC, Merit Medical Systems Inc., Penumbra Inc, Shape Memory Medical Inc., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates Inc., and WEGO Healthcare Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Vascular Embolization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Embolization Technique, market is studied across Coiling Devices and Non-Coiling Devices.
  • Based on Application, market is studied across Neurology, Oncology, Peripheral Vascular Disease, and Urology.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostics Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of vascular diseases
      • 5.1.1.2. Increasing preference for minimally invasive procedures
      • 5.1.1.3. Development in embolization products and procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with embolization procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in biomaterials and technologies for vascular embolization
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with embolization procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Embolization Market, by Embolization Technique

  • 6.1. Introduction
  • 6.2. Coiling Devices
  • 6.3. Non-Coiling Devices

7. Vascular Embolization Market, by Application

  • 7.1. Introduction
  • 7.2. Neurology
  • 7.3. Oncology
  • 7.4. Peripheral Vascular Disease
  • 7.5. Urology

8. Vascular Embolization Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostics Centers
  • 8.4. Hospitals
  • 8.5. Specialty Clinics

9. Americas Vascular Embolization Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Vascular Embolization Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Vascular Embolization Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun Melsungen AG
  • 3. Becton, Dickinson and Company
  • 4. Boston Scientific Corporation
  • 5. Cook Medical Inc.
  • 6. Kaneka Corporation
  • 7. Lepu Medical Technology Co.,Ltd.
  • 8. Medtronic PLC
  • 9. Merit Medical Systems Inc.
  • 10. Penumbra Inc
  • 11. Shape Memory Medical Inc.
  • 12. Stryker Corporation
  • 13. Terumo Corporation
  • 14. W. L. Gore & Associates Inc.
  • 15. WEGO Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. VASCULAR EMBOLIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR EMBOLIZATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR EMBOLIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR EMBOLIZATION MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY NON-COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR EMBOLIZATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2023